Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 00:40 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Pilot Study of Bisphosphonates for Breast Cancer
NCT02781805 · University of Wisconsin, Madison · PHASE1 · terminated · last registry update 2020-10-22 · Breast cancer · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
No reason was published
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | The registry record gives no reason | – | Registry record, University of Wisconsin, Madison |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against FDPS in breast cancer within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2021-06-22Also stopped (terminated): First Affiliated Hospital, Sun Yat-Sen University, Zoledronate (NCT01623908)
- 2020-05-12Results posted on the registry: University of California, San Francisco, Zoledronic Acid (NCT00295867)
- 2020-04-28Results posted on the registry: City of Hope Medical Center, zoledronic acid (NCT01409811)
- 2020-03-24Results posted on the registry: Gynecologic Oncology Group, Zoledronic Acid (NCT00305695)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision